Differences in Leukocyte Telomere Length between Coronary Heart Disease and Normal Population: A Multipopulation

Xiaofeng Xu1, Haochang Hu1, Ying Lin1

  • 1Medical Genetics Center, School of Medicine, Ningbo University, Ningbo 315000, Zhejiang, China.

Insights

Leukocyte telomere length is significantly shorter in patients with coronary heart disease (CHD). Shorter telomeres correlate with CHD severity, particularly in Asian men and younger individuals, warranting further mechanistic research.

Area of Science:

  • Cardiovascular Research
  • Genetics
  • Aging

Background:

  • Coronary heart disease (CHD) is a leading global cause of mortality.
  • Leukocyte telomere length (LTL) has been linked to atherosclerotic disease progression and cardiovascular mortality.
  • Existing research on LTL and CHD shows inconsistent findings due to methodological variations.

Purpose of the Study:

  • To systematically evaluate the association between LTL and CHD.
  • To investigate the correlation between LTL and the severity of coronary heart disease.
  • To identify subgroups with the most pronounced LTL differences in CHD patients.

Main Methods:

  • A comprehensive literature search was conducted across five major databases: Pubmed, Web of Science, Embase, CNKI, and Wangfang.
  • Meta-analysis included 18 eligible studies comprising 5,150 CHD patients and 9,341 controls.
  • Subgroup analyses were performed based on ethnicity, age, and sex.

Main Results:

  • Patients with CHD exhibited significantly shorter LTL compared to control groups.
  • A significant inverse correlation was observed between LTL and the severity of CHD.
  • Telomere shortening was most pronounced in Asian CHD patients, those under 65 years, and male patients.

Conclusions:

  • Reduced LTL is a significant indicator associated with coronary heart disease.
  • LTL may serve as a biomarker for CHD severity and progression.
  • Further research is needed to elucidate the mechanisms linking telomere shortening to CHD pathogenesis.

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
26.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
922
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
391
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
223
Conservation of Small Populations02:04

Conservation of Small Populations

Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
16.7K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
467